{"id":15594,"date":"2025-01-15T07:17:18","date_gmt":"2025-01-15T06:17:18","guid":{"rendered":"https:\/\/helloproject.es\/vigilancia\/espana-lider-europeo-en-investigacion-clinica-de-medicamentos\/"},"modified":"2025-01-15T07:17:18","modified_gmt":"2025-01-15T06:17:18","slug":"espana-lider-europeo-en-investigacion-clinica-de-medicamentos","status":"publish","type":"post","link":"https:\/\/helloproject.es\/vigilancia\/espana-lider-europeo-en-investigacion-clinica-de-medicamentos\/","title":{"rendered":"Espa\u00f1a, l\u00edder europeo en investigaci\u00f3n cl\u00ednica de medicamentos"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.infosalut.com\/images\/noticies\/cc\/cc-acc137.jpg\" \/><\/p>\n<p>Seg\u00fan el <a href=\"https:\/\/reec.aemps.es\/reec\/public\/web.html\" target=\"_blank\" rel=\"noopener\">Registro Espa\u00f1ol de Estudios Cl\u00ednicos (REec)<\/a>, la <a href=\"https:\/\/www.aemps.gob.es\/\" target=\"_blank\" rel=\"noopener\">Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios (AEMPS)<\/a> autoriz\u00f3 el <strong>a\u00f1o pasado un total de 930 estudios<\/strong>, convirti\u00e9ndose en la <strong>agencia reguladora que m\u00e1s ensayos cl\u00ednicos ha aprobado<\/strong>, por delante de las de pa\u00edses como Francia o Alemania.<\/p>","protected":false},"excerpt":{"rendered":"<p>Seg\u00fan el Registro Espa\u00f1ol de Estudios Cl\u00ednicos (REec), la Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios (AEMPS) autoriz\u00f3 el a\u00f1o pasado un total de 930 estudios, convirti\u00e9ndose en la agencia reguladora que m\u00e1s ensayos cl\u00ednicos ha aprobado, por delante de las de pa\u00edses como Francia o Alemania.<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[5],"tags":[],"class_list":["post-15594","post","type-post","status-publish","format-standard","hentry","category-noticias"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.9 (Yoast SEO v27.6) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Espa\u00f1a, l\u00edder europeo en investigaci\u00f3n cl\u00ednica de medicamentos - bip4ex<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/helloproject.es\/vigilancia\/espana-lider-europeo-en-investigacion-clinica-de-medicamentos\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Espa\u00f1a, l\u00edder europeo en investigaci\u00f3n cl\u00ednica de medicamentos\" \/>\n<meta property=\"og:description\" content=\"Seg\u00fan el Registro Espa\u00f1ol de Estudios Cl\u00ednicos (REec), la Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios (AEMPS) autoriz\u00f3 el a\u00f1o pasado un total de 930 estudios, convirti\u00e9ndose en la agencia reguladora que m\u00e1s ensayos cl\u00ednicos ha aprobado, por delante de las de pa\u00edses como Francia o Alemania.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/helloproject.es\/vigilancia\/espana-lider-europeo-en-investigacion-clinica-de-medicamentos\/\" \/>\n<meta property=\"og:site_name\" content=\"bip4ex\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-15T06:17:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.infosalut.com\/images\/noticies\/cc\/cc-acc137.jpg\" \/>\n<meta name=\"author\" content=\"Luis Miguel Mej\u00edas Ramos\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Luis Miguel Mej\u00edas Ramos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/espana-lider-europeo-en-investigacion-clinica-de-medicamentos\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/espana-lider-europeo-en-investigacion-clinica-de-medicamentos\\\/\"},\"author\":{\"name\":\"Luis Miguel Mej\u00edas Ramos\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#\\\/schema\\\/person\\\/3767b0619d59a11570372c821f8619ca\"},\"headline\":\"Espa\u00f1a, l\u00edder europeo en investigaci\u00f3n cl\u00ednica de medicamentos\",\"datePublished\":\"2025-01-15T06:17:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/espana-lider-europeo-en-investigacion-clinica-de-medicamentos\\\/\"},\"wordCount\":67,\"publisher\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/espana-lider-europeo-en-investigacion-clinica-de-medicamentos\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.infosalut.com\\\/images\\\/noticies\\\/cc\\\/cc-acc137.jpg\",\"articleSection\":[\"Noticias\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/espana-lider-europeo-en-investigacion-clinica-de-medicamentos\\\/\",\"url\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/espana-lider-europeo-en-investigacion-clinica-de-medicamentos\\\/\",\"name\":\"Espa\u00f1a, l\u00edder europeo en investigaci\u00f3n cl\u00ednica de medicamentos - bip4ex\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/espana-lider-europeo-en-investigacion-clinica-de-medicamentos\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/espana-lider-europeo-en-investigacion-clinica-de-medicamentos\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.infosalut.com\\\/images\\\/noticies\\\/cc\\\/cc-acc137.jpg\",\"datePublished\":\"2025-01-15T06:17:18+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/espana-lider-europeo-en-investigacion-clinica-de-medicamentos\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/espana-lider-europeo-en-investigacion-clinica-de-medicamentos\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/espana-lider-europeo-en-investigacion-clinica-de-medicamentos\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.infosalut.com\\\/images\\\/noticies\\\/cc\\\/cc-acc137.jpg\",\"contentUrl\":\"https:\\\/\\\/www.infosalut.com\\\/images\\\/noticies\\\/cc\\\/cc-acc137.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/espana-lider-europeo-en-investigacion-clinica-de-medicamentos\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Espa\u00f1a, l\u00edder europeo en investigaci\u00f3n cl\u00ednica de medicamentos\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#website\",\"url\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/\",\"name\":\"bip4ex\",\"description\":\"Vigilancia Tecnol\u00f3gica\",\"publisher\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#organization\",\"name\":\"Helloproject.es\",\"url\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/bip4ex.png\",\"contentUrl\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/bip4ex.png\",\"width\":322,\"height\":365,\"caption\":\"Helloproject.es\"},\"image\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#\\\/schema\\\/person\\\/3767b0619d59a11570372c821f8619ca\",\"name\":\"Luis Miguel Mej\u00edas Ramos\",\"url\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/author\\\/luismi\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Espa\u00f1a, l\u00edder europeo en investigaci\u00f3n cl\u00ednica de medicamentos - bip4ex","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/helloproject.es\/vigilancia\/espana-lider-europeo-en-investigacion-clinica-de-medicamentos\/","og_locale":"es_ES","og_type":"article","og_title":"Espa\u00f1a, l\u00edder europeo en investigaci\u00f3n cl\u00ednica de medicamentos","og_description":"Seg\u00fan el Registro Espa\u00f1ol de Estudios Cl\u00ednicos (REec), la Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios (AEMPS) autoriz\u00f3 el a\u00f1o pasado un total de 930 estudios, convirti\u00e9ndose en la agencia reguladora que m\u00e1s ensayos cl\u00ednicos ha aprobado, por delante de las de pa\u00edses como Francia o Alemania.","og_url":"https:\/\/helloproject.es\/vigilancia\/espana-lider-europeo-en-investigacion-clinica-de-medicamentos\/","og_site_name":"bip4ex","article_published_time":"2025-01-15T06:17:18+00:00","og_image":[{"url":"https:\/\/www.infosalut.com\/images\/noticies\/cc\/cc-acc137.jpg","type":"","width":"","height":""}],"author":"Luis Miguel Mej\u00edas Ramos","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Luis Miguel Mej\u00edas Ramos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/helloproject.es\/vigilancia\/espana-lider-europeo-en-investigacion-clinica-de-medicamentos\/#article","isPartOf":{"@id":"https:\/\/helloproject.es\/vigilancia\/espana-lider-europeo-en-investigacion-clinica-de-medicamentos\/"},"author":{"name":"Luis Miguel Mej\u00edas Ramos","@id":"https:\/\/helloproject.es\/vigilancia\/#\/schema\/person\/3767b0619d59a11570372c821f8619ca"},"headline":"Espa\u00f1a, l\u00edder europeo en investigaci\u00f3n cl\u00ednica de medicamentos","datePublished":"2025-01-15T06:17:18+00:00","mainEntityOfPage":{"@id":"https:\/\/helloproject.es\/vigilancia\/espana-lider-europeo-en-investigacion-clinica-de-medicamentos\/"},"wordCount":67,"publisher":{"@id":"https:\/\/helloproject.es\/vigilancia\/#organization"},"image":{"@id":"https:\/\/helloproject.es\/vigilancia\/espana-lider-europeo-en-investigacion-clinica-de-medicamentos\/#primaryimage"},"thumbnailUrl":"https:\/\/www.infosalut.com\/images\/noticies\/cc\/cc-acc137.jpg","articleSection":["Noticias"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/helloproject.es\/vigilancia\/espana-lider-europeo-en-investigacion-clinica-de-medicamentos\/","url":"https:\/\/helloproject.es\/vigilancia\/espana-lider-europeo-en-investigacion-clinica-de-medicamentos\/","name":"Espa\u00f1a, l\u00edder europeo en investigaci\u00f3n cl\u00ednica de medicamentos - bip4ex","isPartOf":{"@id":"https:\/\/helloproject.es\/vigilancia\/#website"},"primaryImageOfPage":{"@id":"https:\/\/helloproject.es\/vigilancia\/espana-lider-europeo-en-investigacion-clinica-de-medicamentos\/#primaryimage"},"image":{"@id":"https:\/\/helloproject.es\/vigilancia\/espana-lider-europeo-en-investigacion-clinica-de-medicamentos\/#primaryimage"},"thumbnailUrl":"https:\/\/www.infosalut.com\/images\/noticies\/cc\/cc-acc137.jpg","datePublished":"2025-01-15T06:17:18+00:00","breadcrumb":{"@id":"https:\/\/helloproject.es\/vigilancia\/espana-lider-europeo-en-investigacion-clinica-de-medicamentos\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/helloproject.es\/vigilancia\/espana-lider-europeo-en-investigacion-clinica-de-medicamentos\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/helloproject.es\/vigilancia\/espana-lider-europeo-en-investigacion-clinica-de-medicamentos\/#primaryimage","url":"https:\/\/www.infosalut.com\/images\/noticies\/cc\/cc-acc137.jpg","contentUrl":"https:\/\/www.infosalut.com\/images\/noticies\/cc\/cc-acc137.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/helloproject.es\/vigilancia\/espana-lider-europeo-en-investigacion-clinica-de-medicamentos\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/helloproject.es\/vigilancia\/"},{"@type":"ListItem","position":2,"name":"Espa\u00f1a, l\u00edder europeo en investigaci\u00f3n cl\u00ednica de medicamentos"}]},{"@type":"WebSite","@id":"https:\/\/helloproject.es\/vigilancia\/#website","url":"https:\/\/helloproject.es\/vigilancia\/","name":"bip4ex","description":"Vigilancia Tecnol\u00f3gica","publisher":{"@id":"https:\/\/helloproject.es\/vigilancia\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/helloproject.es\/vigilancia\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/helloproject.es\/vigilancia\/#organization","name":"Helloproject.es","url":"https:\/\/helloproject.es\/vigilancia\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/helloproject.es\/vigilancia\/#\/schema\/logo\/image\/","url":"https:\/\/helloproject.es\/vigilancia\/wp-content\/uploads\/2023\/07\/bip4ex.png","contentUrl":"https:\/\/helloproject.es\/vigilancia\/wp-content\/uploads\/2023\/07\/bip4ex.png","width":322,"height":365,"caption":"Helloproject.es"},"image":{"@id":"https:\/\/helloproject.es\/vigilancia\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/helloproject.es\/vigilancia\/#\/schema\/person\/3767b0619d59a11570372c821f8619ca","name":"Luis Miguel Mej\u00edas Ramos","url":"https:\/\/helloproject.es\/vigilancia\/author\/luismi\/"}]}},"_links":{"self":[{"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/posts\/15594","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/comments?post=15594"}],"version-history":[{"count":0,"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/posts\/15594\/revisions"}],"wp:attachment":[{"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/media?parent=15594"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/categories?post=15594"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/tags?post=15594"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}